Trideum Biosciences Announces Antimicrobial Efficacy of a Novel Cold Plasma Technology Developed by ChiScan

Share Article

Trideum Biosciences revealed the results of their antimicrobial efficacy testing of ChiScan Cold Plasma technology.

Trideum Biosciences revealed the results of their antimicrobial efficacy testing of ChiScan Cold Plasma technology. “Our laboratory has been conducting efficacy testing of this novel next-generation cold plasma technology and I am pleased to announce our testing results demonstrated effectiveness against all the bacterial and fungal pathogens tested” said Dr. Mina Izadjoo, VP and Chief Science Officer of Trideum Biosciences. She also added “We have selected Dr. Hosan Kim, who has extensive experience in antimicrobial efficacy evaluation, to conduct the ongoing testing. The results of antimicrobial testing have been presented in a number of scientific conferences and will be published in peer reviewed journals. This revolutionary cold plasma technology is a promising antibacterial and antifungal medical device for treating localized bacterial and dermatophytic infections and can be used as a countermeasure for multidrug-resistant and hard-to-treat infectious agents.”

Huan Trung, President and CEO of ChiScan LLC, said “We are thrilled to learn of the superior antimicrobial efficacy of our device which is the result of more than 10 years of Research and Development by our team of talented engineers. Our technology will revolutionize the cold plasma field.” He added, “Although currently there a number of technologies capable of generating cold plasma, our proprietary cold plasma generating technology is novel due to its size, being portable with no requirement for any noble gas, its precision, robustness, and ease of application.”

“Trideum Biosciences is committed to providing solutions for hard-to-treat human diseases and we are thrilled to be part of this revolutionary technology,” said Favio Lopez, VP and Chief Operations Officer. Van Sullivan, President and CEO of Trideum Biosciences, said “We are very pleased to have entered into a collaborative partnership with ChiScan and looking forward to many years of a productive collaboration”.

About Trideum Biosciences LLC

Trideum BioSciences (TBS) LLC is a Maryland limited liability company located in Frederick, Maryland. TBS is an ‘open source’ technology evaluation and development company with extensive experience in preclinical and clinical research including antimicrobial efficacy evaluation of candidate therapeutics and devices. TBS’s focus is on practical scientific solutions to both commercial and government agencies, and with fully-equipped labs, has all of the essential elements for performing work with live microorganisms. POC: mizadjoo(at)trideumbiosciences(dot)com

About ChiScan LLC

ChiScan LLC located in Tempe, Arizona was formed by a group of experienced, innovative and passionate engineers with backgrounds in providing solutions for complex problems based on physics, microchip engineering, information and manufacturing technology. Our collaborating and reach-back laboratories for technology evaluation and efficacy testing are located in Washington, DC area. POC: huan(at)chiscan(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Joe Yearta

Dr. Mina Izadjoo
Visit website